Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Data sources

SEC FORM 47m ago

HOUSE PTR6m ago

SEC 13F6m ago

ROBINHOOD CHAIN6m ago

Public company

Apnimed, Inc.

APMDCIK 0001745648

EDGAR filings Open in network

Price$15.10

1 year-39.6%

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections with evidence3

APMD · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
← Holds over 5% ofevidence
SHIONOGI & CO LTD7.1% of class · Schedule 13G · Nov 3, 2026
← Lobbied forevidence
CROSSROADS STRATEGIES, LLCLDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026

Lobbying

$20K reported · de-duplicated

2026 Q2 $0 via firms2026 Q1 $20K via firms

CROSSROADS STRATEGIES, LLC—2026 Q2 · posted Aug 26, 2026 ·
CROSSROADS STRATEGIES, LLC$20K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.

Planned sales and 5% stakes

Form 144, 13D and 13G

SHIONOGI & CO LTDPassive holder · crossed on Sep 30, 2026 · 2.95M shares7.1% of class13G · filed Nov 4, 2026